Skip to main content
. 2017 Nov 22;8(68):112598–112609. doi: 10.18632/oncotarget.22607

Table 2. CA 19-9 level and RFS.

U/mL Frequency (%) Cox (univariable)
Total No event Event HR (95% CI) p-value
≤ 22.9* 31 12 (38.7) 19 (61.3) 1
> 22.9* 50 9 (18.0) 41 (82.0) 1.50 (0.87–12.60) 0.1454
≤ 37 40 12 (30.0) 28 (70.0) 1
> 37 41 9 (22.0) 32 (78.1) 1.30 (0.78–2.16) 0.3180
≤ 100 56 17 (30.4) 39 (69.6) 1
> 100 25 4 (16.0) 21 (84.0) 1.53 (0.90–2.61) 0.1178
≤ 1000 72 20 (27.8) 52 (72.2) 1
> 1000 9 1 (11.1) 8 (88.9) 2.04 (0.96–4.33) 0.0627

*The cutoff was determined to maximize the differences between groups in terms of the log-rank test statistic.